CJC-1295 5mg

• Net Content:
• Purity:
• Common Research Areas: Extended GHRH receptor activation, somatotroph biology, growth hormone axis pharmacokinetics
• Storage: Store at -20°C. Keep away from light and moisture.
• For Research Use Only — Not for Human or Animal Consumption

CJC-1295 with DAC (Drug Affinity Complex) is a modified synthetic analog of growth hormone-releasing hormone (GHRH) designed to extend binding duration at the GHRH receptor. The DAC modification facilitates covalent binding to albumin, extending the half-life and allowing for research into sustained GHRH receptor activation. Applications include studies of prolonged somatotroph stimulation, GHRH receptor pharmacokinetics, and sustained growth hormone axis signaling. Supplied as a lyophilized powder.

All products sold by Peptide Pantry are intended strictly for laboratory research and scientific study purposes only. These compounds are not approved by the FDA for human therapeutic use and are not intended for human or animal consumption, injection, inhalation, or any form of in vivo administration. By purchasing you confirm that you are a qualified researcher and will use these materials solely in a laboratory research context in compliance with all applicable laws and regulations. Must be 18 or older to purchase.